PUBMED FOR HANDHELDS

Journal Abstract Search


877 related items for PubMed ID: 7951524

  • 1. Evaluation of hypothalamo-pituitary-adrenocortical function in children by human corticotropin-releasing hormone (MCI-028) test.
    Tanaka T, Hibi I, Shimizu N, Imura H, Tanaka K, Fukata J, Fujieda K, Ichimura T, Kuribayashi T, Ito K.
    Endocr J; 1993 Oct; 40(5):581-9. PubMed ID: 7951524
    [Abstract] [Full Text] [Related]

  • 2. Human corticotropin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders.
    Fukata J, Shimizu N, Imura H, Hibi I, Tanaka K, Tanaka T, Nakagawa S, Takebe K, Kimura K, Yoshinaga K.
    Endocr J; 1993 Oct; 40(5):597-606. PubMed ID: 7951526
    [Abstract] [Full Text] [Related]

  • 3. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC, Nieman LK, Oldfield EH, Loughlin T, Barnes KM, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [Abstract] [Full Text] [Related]

  • 4. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [Abstract] [Full Text] [Related]

  • 5. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 6. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW, Kling MA, Khan I, Calabrese JR, Kalogeras K, Post RM, Avgerinos PC, Loriaux DL, Chrousos GP.
    Adv Biochem Psychopharmacol; 1987 Dec; 43():183-200. PubMed ID: 3035886
    [Abstract] [Full Text] [Related]

  • 7. Human corticotropin-releasing hormone (hCRH) test: sex and age differences in plasma ACTH and cortisol responses and their reproducibility in healthy adults.
    Tanaka K, Shimizu N, Imura H, Fukata J, Hibi I, Tanaka T, Nakagawa S, Fujieda K, Takebe K, Yoshinaga K.
    Endocr J; 1993 Oct; 40(5):571-9. PubMed ID: 7951523
    [Abstract] [Full Text] [Related]

  • 8. Recovery from glucocorticoid inhibition of the responses to corticotrophin-releasing hormone.
    Watson AC, Rosenfield RL, Fang VS.
    Clin Endocrinol (Oxf); 1988 May; 28(5):471-7. PubMed ID: 2850875
    [Abstract] [Full Text] [Related]

  • 9. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ, Faria M, Newell-Price J, Browne P, Kopelman P, Coy DH, Besser GM, Grossman AB.
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [Abstract] [Full Text] [Related]

  • 10. The use of the corticotropin-releasing hormone test to monitor the recovery of patients with Cushing's disease or Cushing's syndrome due to an adrenal adenoma after adenomectomy.
    Hotta MN, Shibasaki T, Suda T, Ling N, Shizume K.
    Endocrinol Jpn; 1985 Feb; 32(1):113-25. PubMed ID: 2990881
    [Abstract] [Full Text] [Related]

  • 11. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
    Feuillan P, Pang S, Schürmeyer T, Avgerinos PC, Chrousos GP.
    J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
    [Abstract] [Full Text] [Related]

  • 12. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ, Ellis MJ, Evans MJ, Donald RA.
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [Abstract] [Full Text] [Related]

  • 13. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [Abstract] [Full Text] [Related]

  • 14. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
    Isidori AM, Kaltsas GA, Korbonits M, Pyle M, Gueorguiev M, Meinhardt A, Metz C, Petrovsky N, Popovic V, Bucala R, Grossman AB.
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1834-40. PubMed ID: 11932327
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests.
    Maghnie M, Uga E, Temporini F, Di Iorgi N, Secco A, Tinelli C, Papalia A, Casini MR, Loche S.
    Eur J Endocrinol; 2005 May; 152(5):735-41. PubMed ID: 15879359
    [Abstract] [Full Text] [Related]

  • 16. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L, Chrousos GP, Loriaux DL, Barnes K, Munson P, Nieman L, Schaison G.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [Abstract] [Full Text] [Related]

  • 17. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X, Escourolle H, Pinquier JL, Coste J, Raux-Demay MC, Perles P, Silvestre L, Luton JP, Strauch G.
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [Abstract] [Full Text] [Related]

  • 18. Corticotropin-releasing factor in humans. II. CRF stimulation in patients with diseases of the hypothalamo-pituitary-adrenal axis.
    Müller OA, Stalla GK, von Werder K.
    Horm Res; 1987 Feb; 25(4):185-98. PubMed ID: 3034758
    [Abstract] [Full Text] [Related]

  • 19. Corticotropin releasing factor: basic studies and clinical applications.
    Chrousos GP, Calabrese JR, Avgerinos P, Kling MA, Rubinow D, Oldfield EH, Schuermeyer T, Kellner CH, Cutler GB, Loriaux DL.
    Prog Neuropsychopharmacol Biol Psychiatry; 1985 Feb; 9(4):349-59. PubMed ID: 2999871
    [Abstract] [Full Text] [Related]

  • 20. Responsiveness of the hypophyseal-adrenocortical axis to corticotropin-releasing factor in pituitary-dependent Cushing's disease.
    Pieters GF, Hermus AR, Smals AG, Bartelink AK, Benraad TJ, Kloppenborg PW.
    J Clin Endocrinol Metab; 1983 Sep; 57(3):513-6. PubMed ID: 6308029
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 44.